Memorial Sloan Kettering Cancer Center-led researchers have identified a small molecule called gliocidin that kills ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among ...

Topics include computed tomography scans (CTs) for staging, new therapies, the melanoma vaccine, the BRAF test, and more.

Report with the AI impact on market trends - The global veterinary eye care market size is estimated to grow by USD 1.05 ...

A three-legged cat is looking for a place to call home after a rough start to life that led to an amputation. Long John ...

Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) treatment does not work. There is no official definition or set criteria for TRD, but the measure often used is an ...

Former New Jersey Gov. Chris Christie (R) said on Sunday he agrees with Rep. Ritchie Torres (D-N.Y.) that the far left helped ...

The cost of Embrace pet insurance plans in New Jersey is on par with the average rates of companies in our analysis. However, Embrace covers more advanced treatments than many competitors ...

India is witnessing a surge in cancer cases, with an estimated 800,000 new diagnoses annually. The increase is attributed to lifestyle changes, tobacco use, and alarming levels of air pollution ...

The FDA has approved a new treatment, Aucatzyl, for a type of aggressive blood cancer called B-cell acute lymphoblastic leukemia (B-cell ALL). This treatment, a CAR T-cell immunotherapy ...